Mechanisms of podocyte injury and implications for diabetic nephropathy

被引:97
|
作者
Barutta, Federica [1 ]
Bellini, Stefania [1 ]
Gruden, Gabriella [1 ]
机构
[1] Univ Turin, Dept Med Sci, Turin, Italy
关键词
GLYCATION END-PRODUCTS; CANNABINOID RECEPTOR 1; SHARED TRANSCRIPTIONAL NETWORKS; NLRP3 INFLAMMASOME ACTIVATION; GLOMERULAR-FILTRATION-RATE; GLUCAGON-LIKE PEPTIDE-1; KIDNEY-DISEASE; MITOCHONDRIAL DYSFUNCTION; HIGH-GLUCOSE; NEPHROTIC SYNDROME;
D O I
10.1042/CS20210625
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine. The kidneys filter approximately 180 l of fluids everyday; however, there is no loss of proteins into urine as the glomerular filtration barrier (GFB) retains 99.99% of plasma proteins. Alterations in the GFB result in the development of proteinuria, ranging from albuminuria to massive nephrotic syndrome. Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), diabetic nephropathy (DN), obesity-related nephropathy, and an important feature of chronic kidney diseases (CKDs). In addition, in patients with CKD, albuminuria is a predictor of progression towards end-stage renal disease (ESRD) and is associated with an increased risk of cardiovascular diseases. Glomerular podocytes are a component of the GFB and podocyte injury is the main cause of albuminuria development. Herein, we will describe patterns of podocyte damage and review underlying mechanisms, focussing particularly on DN.
引用
收藏
页码:493 / 520
页数:28
相关论文
共 50 条
  • [31] Podocyte loss and progression of diabetic nephropathy
    Shirato, I
    Hishiki, T
    Tomino, Y
    TYPE-2 DIABETIC NEPHROPATHY IN JAPAN: FROM BENCH TO BEDSIDE, 2001, 134 : 69 - 73
  • [33] Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse
    Loeffler, Ivonne
    Ruester, Christiane
    Franke, Sybille
    Liebisch, Marita
    Wolf, Gunter
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (06) : F911 - F918
  • [34] miR-1187 induces podocyte injury and diabetic nephropathy through autophagy
    Chen, Bin
    He, Qiang
    DIABETES & VASCULAR DISEASE RESEARCH, 2023, 20 (02):
  • [35] Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy
    Jung, Eunsoo
    Kim, Junghyun
    Kim, Sung Ho
    Kim, Sanghwa
    Cho, Myung-Haing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 761 : 116 - 124
  • [36] Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy
    Kang, Jeong Suk
    Son, Seung Seob
    Lee, Ji-Hye
    Lee, Seong Woo
    Jeong, Ah Reum
    Lee, Eun Soo
    Cha, Seung-Kuy
    Chung, Choon Hee
    Lee, Eun Young
    PLOS ONE, 2021, 16 (04):
  • [37] Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy
    Ma, Ruixia
    Liu, Liqiu
    Liu, Xuemei
    Wang, Yan
    Jiang, Wei
    Xu, Luo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (03) : 649 - 656
  • [38] Lack of α8-integrin aggravates podocyte injury in experimental diabetic nephropathy
    Hartner, Andrea
    Cordasic, Nada
    Menendez-Castro, Carlos
    Volkert, Gudrun
    Yabu, Julie M.
    Kupraszewicz-Hutzler, Miroslava
    Rascher, Wolfgang
    Hilgers, Karl F.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 299 (05) : F1151 - F1157
  • [39] Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes
    Dalla Vestra, M
    Masiero, A
    Roiter, AM
    Saller, A
    Crepaldi, G
    Fioretto, P
    DIABETES, 2003, 52 (04) : 1031 - 1035
  • [40] Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy
    Wang, Tao
    Gao, Yanbin
    Wang, Xiaolei
    Shi, Yimin
    Xu, Jiayi
    Wu, Bingjie
    He, Jiaxin
    Li, Yimeng
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1811 - 1820